FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2908039851> ?p ?o ?g. }

• W2908039851 endingPage "374" @default.
• W2908039851 startingPage "362" @default.
• W2908039851 abstract "Upon viral infection, the interferon (IFN) system triggers potent antiviral mechanisms limiting viral growth and spread. Hence, to sustain their infection, viruses evolved efficient counteracting strategies to evade IFN control. Ebola virus (EBOV), member of the family Filoviridae, is one of the most virulent and deadly pathogen ever faced by humans. The etiological agent of the Ebola Virus Disease (EVD), EBOV can be undoubtedly considered the perfect example of a powerful inhibitor of the host organism immune response activation. Particularly, the efficacious suppression of the IFN cascade contributes to disease progression and severity. Among the EBOVencoded proteins, the Viral Proteins 35 (VP35) and 24 (VP24) are responsible for the EBOV extreme virulence, representing the core of such inhibitory function through which EBOV determines its very effective shield to the cellular immune defenses. VP35 inhibits the activation of the cascade leading to IFN production, while VP24 inhibits the activation of the IFN-stimulated genes. A number of studies demonstrated that both VP35 and VP24 is validated target for drug development. Insights into the structural characteristics of VP35 and VP24 domains revealed crucial pockets exploitable for drug development. Considered the lack of therapy for EVD, restoring the immune activation is a promising approach for drug development. In the present review, we summarize the importance of VP35 and VP24 proteins in counteracting the host IFN cellular response and discuss their potential as druggable viral targets as a promising approach toward attenuation of EBOV virulence." @default.
• W2908039851 created "2019-01-11" @default.
• W2908039851 creator A5036810939 @default.
• W2908039851 creator A5037425032 @default.
• W2908039851 creator A5056464448 @default.
• W2908039851 creator A5063748153 @default.
• W2908039851 date "2019-12-23" @default.
• W2908039851 modified "2023-10-16" @default.
• W2908039851 title "Insights into Ebola Virus VP35 and VP24 Interferon Inhibitory Functions and their Initial Exploitation as Drug Targets" @default.
• W2908039851 cites W131140191 @default.
• W2908039851 cites W1667782349 @default.
• W2908039851 cites W1812222217 @default.
• W2908039851 cites W1907184281 @default.
• W2908039851 cites W1963498694 @default.
• W2908039851 cites W1964316194 @default.
• W2908039851 cites W1971386891 @default.
• W2908039851 cites W1972285445 @default.
• W2908039851 cites W1976117598 @default.
• W2908039851 cites W1977292892 @default.
• W2908039851 cites W1979225287 @default.
• W2908039851 cites W1986790321 @default.
• W2908039851 cites W1987105457 @default.
• W2908039851 cites W1993332077 @default.
• W2908039851 cites W1993510145 @default.
• W2908039851 cites W1997936078 @default.
• W2908039851 cites W1998041119 @default.
• W2908039851 cites W2003058341 @default.
• W2908039851 cites W2005121650 @default.
• W2908039851 cites W2010072146 @default.
• W2908039851 cites W2012052755 @default.
• W2908039851 cites W2012588545 @default.
• W2908039851 cites W2013913832 @default.
• W2908039851 cites W2016248631 @default.
• W2908039851 cites W2017700325 @default.
• W2908039851 cites W2018568861 @default.
• W2908039851 cites W2018828712 @default.
• W2908039851 cites W2026437351 @default.
• W2908039851 cites W2026660010 @default.
• W2908039851 cites W2031182394 @default.
• W2908039851 cites W2031320723 @default.
• W2908039851 cites W2031437584 @default.
• W2908039851 cites W2032376562 @default.
• W2908039851 cites W2034487380 @default.
• W2908039851 cites W2036199536 @default.
• W2908039851 cites W2036436901 @default.
• W2908039851 cites W2040132891 @default.
• W2908039851 cites W2040653543 @default.
• W2908039851 cites W2050963689 @default.
• W2908039851 cites W2052982889 @default.
• W2908039851 cites W2053240860 @default.
• W2908039851 cites W2053476949 @default.
• W2908039851 cites W2055231449 @default.
• W2908039851 cites W2057559854 @default.
• W2908039851 cites W2059118814 @default.
• W2908039851 cites W2060004514 @default.
• W2908039851 cites W2060297381 @default.
• W2908039851 cites W2061482476 @default.
• W2908039851 cites W2065939419 @default.
• W2908039851 cites W2067231055 @default.
• W2908039851 cites W2067678108 @default.
• W2908039851 cites W2070362953 @default.
• W2908039851 cites W2071229331 @default.
• W2908039851 cites W2074514239 @default.
• W2908039851 cites W2076938612 @default.
• W2908039851 cites W2077494922 @default.
• W2908039851 cites W2078645984 @default.
• W2908039851 cites W2078844752 @default.
• W2908039851 cites W2079162651 @default.
• W2908039851 cites W2084880831 @default.
• W2908039851 cites W2086984586 @default.
• W2908039851 cites W2093579074 @default.
• W2908039851 cites W2094597469 @default.
• W2908039851 cites W2094993149 @default.
• W2908039851 cites W2095606194 @default.
• W2908039851 cites W2096701457 @default.
• W2908039851 cites W2098188064 @default.
• W2908039851 cites W2098725806 @default.
• W2908039851 cites W2099533608 @default.
• W2908039851 cites W2100827617 @default.
• W2908039851 cites W2100878564 @default.
• W2908039851 cites W2102286438 @default.
• W2908039851 cites W2103565638 @default.
• W2908039851 cites W2105746066 @default.
• W2908039851 cites W2106587802 @default.
• W2908039851 cites W2107513655 @default.
• W2908039851 cites W2111739562 @default.
• W2908039851 cites W2112449136 @default.
• W2908039851 cites W2115597041 @default.
• W2908039851 cites W2116029690 @default.
• W2908039851 cites W2121408365 @default.
• W2908039851 cites W2124098175 @default.
• W2908039851 cites W2131583337 @default.
• W2908039851 cites W2133402546 @default.
• W2908039851 cites W2136920638 @default.
• W2908039851 cites W2137303998 @default.
• W2908039851 cites W2137587180 @default.
• W2908039851 cites W2137627132 @default.
• W2908039851 cites W2138789026 @default.

• next